Mercedes N. Overton
FDA investigator
Appears on 2 documents from 2025, mostly at sites in Texas. Most often cites production record review (21 CFR 211.192).
- 2
- Documents on file
- 7.5
- Observations per 483
- 2025
- First seen
- 2025
- Most recent
What they cite most
From 15 observations- 21 CFR 211.192Production record review2
- 21 CFR 211.22(d)Responsibilities of quality control unit2
- 21 CFR 211.101(d)Charge-in of components1
- 21 CFR 211.113(a)Control of microbiological contamination1
- 21 CFR 211.130(a)Packaging and labeling operations1
- 21 CFR 211.160(b)General requirements1
Activity by year
2025: 2
Where
Texas 2
Often inspects with
Is Mercedes N. Overton coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-10-31 | 483 BioMed Laboratories, LLCOct 31, 2025 · Dallas, Texas | Dallas, Texas | 7 | |
| 2025-08-15 | Amended 483 United Laboratories Manufacturing, LLCAug 15, 2025 · Carrollton, Texas | Carrollton, Texas | 8 |
About this profile
What does Mercedes N. Overton inspect?
Mercedes N. Overton appears on 2 documents on file covering 2 sites, mostly in Texas.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.22(d) and 21 CFR 211.101(d).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Mercedes N. Overton is dated Oct 31, 2025.